Christine Lindenboom | executive |
Yvonne Greenstreet | executive |
Tolga Tanguler | executive |
Akshay Vaishnaw | executive |
Jeffrey Poulton | executive |
Ritu Baral | analyst |
Pushkal Garg | executive |
Tazeen Ahmad | analyst |
Sarah Krupp | analyst |
Tommie Reerink | analyst |
Paul Matteis | analyst |
Jialiang Liang | analyst |
Huidong Wang | analyst |
Michael Ulz | analyst |
Konstantinos Biliouris | analyst |
Thank you for standing by, and welcome to the Alnylam Pharmaceuticals First Quarter 2023 Financial Results Conference Call.
As a reminder, today's conference call is being recorded.
I would now like to turn the conference over to the company. Please go ahead.
Good morning.